Cellebrite Di Ltd. (CLBT) — SEC Filings
Cellebrite Di Ltd. (CLBT) — 32 SEC filings. Latest: 6-K (Dec 2, 2025). Includes 24 6-K, 3 SC 13G/A, 2 20-F.
View Cellebrite Di Ltd. on SEC EDGAR
Overview
Cellebrite Di Ltd. (CLBT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Nov 12, 2025: Cellebrite DI Ltd. announced its third-quarter 2025 results via a press release on November 12, 2025. The press release, furnished as Exhibit 99.1, is incorporated by reference into this Form 6-K filing.
Sentiment Summary
Across 32 filings, the sentiment breakdown is: 2 bullish, 30 neutral. The dominant filing sentiment for Cellebrite Di Ltd. is neutral.
Filing Type Overview
Cellebrite Di Ltd. (CLBT) has filed 24 6-K, 2 20-F, 2 SC 13D/A, 1 20-F/A, 3 SC 13G/A with the SEC between Feb 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (32)
Risk Profile
Risk Assessment: Of CLBT's 30 recent filings, 0 were flagged as high-risk, 7 as medium-risk, and 23 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Thomas E. Hogan
- David Barter
- Dana Gerner
- Adam H. Clammer
- James H. Greene Jr.
- Troy K. Richardson
- Haim Shani
- Maya Bareket
- Jonathan Nathan, Adv.
Industry Context
Cellebrite operates in the software services industry, specifically focusing on digital intelligence solutions.
Top Tags
earnings (7) · financial-results (4) · shareholder-meeting (4) · corporate-governance (4) · foreign-private-issuer (4) · warrants (4) · redemption (4) · leadership-change (3) · filing (3) · 20-F (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Fiscal Year End | 2024-12-31 | The report covers the full fiscal year ending on this date. |
| Filing Date | 2025-03-18 | The date the 20-F report was officially submitted to the SEC. |
| Public Document Count | 209 | Indicates the total number of documents included in this filing. |
| Average Share Price Threshold | $17.50 | Minimum average price required for Triggering Event III |
| Trading Days | 20 | Number of days the share price met the threshold |
| Trading Day Period | 30 | The window within which the 20 days must occur |
| Share Price Threshold | $15.00 | The dollar volume-weighted average price of ordinary shares needed to be at or above this amount. |
| Average Share Price | $12.50 | Minimum price achieved for 20 trading days |
| Ordinary Shares Outstanding | 205,297,065 | As of March 11, 2024 |
| Accession Number | 0001854587-24-000018 | Unique identifier for the filing |
| Shares Beneficially Owned | 95,597,718 | Represents SUNCORPORATION's total ownership in Cellebrite DI Ltd. as of December 31, 2023. |
| Date of Event | December 31, 2023 | The specific date for which the ownership data is reported in the filing. |
Forward-Looking Statements
- {"claim":"SUNCORPORATION will maintain its significant ownership stake in Cellebrite DI Ltd.","entity":"SUNCORPORATION","targetDate":"December 31, 2024","confidence":"medium"}
Frequently Asked Questions
What are the latest SEC filings for Cellebrite Di Ltd. (CLBT)?
Cellebrite Di Ltd. has 32 recent SEC filings from Feb 2024 to Dec 2025, including 24 6-K, 3 SC 13G/A, 2 20-F. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of CLBT filings?
Across 32 filings, the sentiment breakdown is: 2 bullish, 30 neutral. The dominant sentiment is neutral.
Where can I find Cellebrite Di Ltd. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Cellebrite Di Ltd. (CLBT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Cellebrite Di Ltd.?
Financial highlights for Cellebrite Di Ltd. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for CLBT?
The investment thesis for CLBT includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Cellebrite Di Ltd.?
Key executives identified across Cellebrite Di Ltd.'s filings include Thomas E. Hogan, David Barter, Dana Gerner, Adam H. Clammer, James H. Greene Jr. and 4 others.
What are the main risk factors for Cellebrite Di Ltd. stock?
Of CLBT's 30 assessed filings, 0 were flagged high-risk, 7 medium-risk, and 23 low-risk.
What are recent predictions and forward guidance from Cellebrite Di Ltd.?
Recent forward-looking statements from Cellebrite Di Ltd. include guidance on {"claim":"SUNCORPORATION will maintain its significant ownership stake in Cellebrite DI Ltd.","entity":"SUNCORPORATION",.